Novartis eyes more bolt-on acquisitions, CEO says
12.01.2026
Jan 12 () - Novartis will continue to do bolt-on deals and its capital allocation priorities remain unchanged, CEO Vasant Narasimhan said at a major industry conference that kicked off on Monday in San Francisco. "We are always looking for opportunities that fit our core therapeutic areas," Narasimhan said at the J.